• PDF / 169,645 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 91 Downloads / 134 Views

DOWNLOAD

REPORT

2-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 19 Sep 2020 No. 862

1

Recommend Documents

Adenocarcinoma in bladder diverticulum, metastatic from gastric cancer

161 31 1MB

Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Pro

150 97 309KB

Primary gastric cancer presenting with a metastatic embolus in the common carotid artery: a case report

181 48 943KB

MicroRNA-based screening cost effective in diagnosing gastric cancer

153 59 182KB

Hospitalisation drives cost to treat metastatic triple-negative breast cancer

118 4 163KB

Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis

166 109 2MB

HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric

161 66 2MB

Effect and cost-effectiveness of national gastric cancer screening in Japan: a microsimulation modeling study

147 81 2MB

A nomogram for predicting survival in patients with de novo metastatic breast cancer: a population-based study

106 36 1MB

A long-term survival case of unresectable gastric cancer with multidisciplinary therapy including immunotherapy and absc

155 104 2MB

Tucatinib not cost effective in metastatic breast cancer in China and US

104 8 163KB

ASO Author Reflections: Surgery Offers Survival Advantage in Treatment-Responsive Metastatic Breast Cancer

107 12 183KB